HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. It ...
Q2 2026
Jul 30, 2026
FY 2025
Mar 5, 2026
Q2 2025
Aug 7, 2025
Q1 2025
May 28, 2025
FY 2024
Mar 19, 2025